Factors associated with stroke or death after carotid endarterectomy in Northern New England

Journal of Vascular Surgery

Volumn 48, Issue 5, 2008, Pages 1139-1145

  Goodney, Philip P ^a   Likosky, Donald S ^a   Cronenwett, Jack L ^a  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TICLOPIDINE;

ARTICLE; CAROTID ARTERY DISEASE; CAROTID ENDARTERECTOMY; CONGESTIVE HEART FAILURE; DEATH; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; INTERNAL CAROTID ARTERY OCCLUSION; MONOTHERAPY; PRIORITY JOURNAL; RISK FACTOR; STROKE; SURGICAL TECHNIQUE; UNITED STATES;

AGE FACTORS; AGED; AGED, 80 AND OVER; CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH STATUS INDICATORS; HEART FAILURE; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; LOGISTIC MODELS; MALE; NEW ENGLAND; ODDS RATIO; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PLATELET AGGREGATION INHIBITORS; PROSPECTIVE STUDIES; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS;

EID: 55049129173     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.05.013     Document Type: Article

References (36)

1. Musser D.J., Nicholas G.G., and Reed III J.F. Death and adverse cardiac events after carotid endarterectomy. J Vasc Surg 19 (1994) 615-622
2. Rothwell P.M., and Warlow C.P. Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. [see comment]. Lancet 353 (1999) 2105-2110
3. Tu J.V., Wang H., Bowyer B., Green L., Fang J., Kucey D., et al. Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario Carotid Endarterectomy Registry. [see comment]. Stroke 34 (2003) 2568-2573
4. Sacco R.L., Benjamin E.J., Broderick J.P., Dyken M., Easton J.D., Feinberg W.M., et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 28 (1999) 1507-1517
5. Kakkos S.K., Nicolaides A., Griffin M., Sabetai M., Dhanjil S., Thomas D.J., et al. Factors associated with mortality in patients with asymptomatic carotid stenosis: results from the ACSRS Study. Int Angiol 24 (2005) 221-230
6. Kresowik T.F., Bratzler D., Karp H.R., Hemann R.A., Hendel M.E., Grund S.L., et al. Multistate utilization, processes, and outcomes of carotid endarterectomy. J Vasc Surg 33 (2001) 227-234 discussion 234-5.
7. Goldstein L.B. Extracranial carotid artery stenosis. Stroke 34 (2003) 2767-2773
8. Frawley J.E., Hicks R.G., and Woodforth I.J. Risk factors for peri-operative stroke complicating carotid endarterectomy: selective analysis of a prospective audit of 1000 consecutive operations. Aust N Z J Surg 70 (2000) 52-56
9. Lindblad B., Persson N.H., Takolander R., and Bergqvist D. Does low-dose acetylsalicylic acid prevent stroke after carotid surgery?. A double-blind, placebo-controlled randomized trial. Stroke 24 (1993) 1125-1128
10. Payne D.A., Jones C.I., Hayes P.D., Naylor A.R., and Goodall A.H. Therapeutic benefit of low-dose clopidogrel in patients undergoing carotid surgery is linked to variability in the platelet adenosine diphosphate response and patients' weight. Stroke 38 (2007) 2464-2469
11. Payne D.A., Jones C.I., Hayes P.D., Thompson M.M., London N.J., Bell P.R., et al. Beneficial effects of clopidogrel combined with aspirin in reducing cerebral emboli in patients undergoing carotid endarterectomy. [see comment]. Circulation 109 (2004) 1476-1481
12. Taylor D.W., Barnett H.J., Haynes R.B., Ferguson G.G., Sackett D.L., Thorpe K.E., et al. Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial. ASA and Carotid Endarterectomy (ACE) Trial Collaborators. [see comment]. Lancet 353 (1999) 2179-2184
13. Halm E.A., Lee C., and Chassin M.R. Is volume related to outcome in health care?. A systematic review and methodologic critique of the literature. [summary for patients in Ann Intern Med. 2002;137:I52; PMID: 12230383]. Ann Intern Med 137 (2002) 511-550
14. Pine M., Jordan H.S., Elixhauser A., Fry D.E., Hoaglin D.C., Jones B., et al. Enhancement of claims data to improve risk adjustment of hospital mortality. JAMA 297 (2007) 71-76
15. Teres D., and Higgins T.L. What if your hospital informatics department could provide a severity adjuster?. [comment]. Crit Care Med 28 (2000) 3570-3571
16. El-Tamer M.B., Ward B.M., Schifftner T., Neumayer L., Khuri S., and Henderson W. Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care. [see comment]. Ann Surg 245 (2007) 665-671
17. Brass E.P., and Hiatt W.R. Review of mortality and cardiovascular event rates in patients enrolled in clinical trials for claudication therapies. Vasc Med 11 (2006) 141-145
18. Wyse R.K.H., and Taylor K.M. Using the STS and multinational cardiac surgical databases to establish risk-adjusted benchmarks for clinical outcomes. Heart Surg Forum 5 (2002) 258-264
19. Peterson E.D., DeLong E.R., Muhlbaier L.H., Rosen A.B., Buell H.E., Kiefe C.I., et al. Challenges in comparing risk-adjusted bypass surgery mortality results: results from the Cooperative Cardiovascular Project. J Am Coll Cardiol 36 (2000) 2174-2184
20. Cronenwett J.L., Russell M.T., Likosky D.S., Eldrup-Jorgensen J., Stanley A.C., Nolan B.W., et al. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSG-NNE). J Vasc Surg 46 (2007) 1093-1101
21. Birkmeyer J.D., Stukel T.A., Siewers A.E., Goodney P.P., Wennberg D.E., and Lucas F.L. Surgeon volume and operative mortality in the United States. [see comment]. N Engl J Med 349 (2003) 2117-2127
22. Cowan Jr. J.A., Dimick J.B., Thompson B.G., Stanley J.C., and Upchurch Jr. G.R. Surgeon volume as an indicator of outcomes after carotid endarterectomy: an effect independent of specialty practice and hospital volume. [see comment]. J Am Coll Surg 195 (2002) 814-821
23. Holt P.J., Poloniecki J.D., Loftus I.M., and Thompson M.M. Meta-analysis and systematic review of the relationship between hospital volume and outcome following carotid endarterectomy. Eur J Vasc Endovasc Surg 33 (2007) 645-651
24. Anonymous. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. [see comment]. JAMA 1421;273:1421-8.
25. Ballotta E., Renon L., Da Giau G., Barbon B., Terranova O., and Baracchini C. Octogenarians with contralateral carotid artery occlusion: a cohort at higher risk for carotid endarterectomy?. J Vasc Surg 39 (2003) 1003-1008
26. Tu J.V., Hannan E.L., Anderson G.M., Wu K., Vranizan K., Popp A.J., et al. The fall and rise of carotid endarterectomy in the United States and Canada. N Engl J Med 339 (1998) 1441-1447
27. Eliasziw M., Streifler J.Y., Spence J.D., Fox A.J., Hachinski V.C., and Barnett H.J. Prognosis for patients following a transient ischemic attack with and without a cerebral infarction on brain CT. North American Symptomatic Carotid Endarterectomy Trial (NASCET) Group. Neurology 45 (1995) 428-431
28. Bhatti A.F., Leon Jr. L.R., Labropoulos N., Rubinas T.L., Rodriguez H., Kalman P.G., et al. Free-floating thrombus of the carotid artery: literature review and case reports. J Vasc Surg 45 (2007) 199-205
29. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. [see comment]. N Engl J Med 325 (1991) 445-453
30. Assadian A., Eidher U., Senekowitsch C., Rotter R., Löchli S., Hagmüller G.W., et al. Antiplatelet therapy prior to carotid endarterectomy-still room for improvement. Vasa 35 (2006) 96-100
31. Cronenwett J.L., Likosky D.S., Russell M.T., Eldrup-Jorgensen J., Stanley A.C., Nolan B.W., et al. A regional registry for quality assurance and improvement: the Vascular Study Group of Northern New England (VSGNNE). J Vasc Surg 46 (2007) 1093-1101 discussion 1101-2.
32. O'Connor G.T., Plume S.K., Olmstead E.M., Morton J.R., Maloney C.T., Nugent W.C., et al. A regional prospective study of in-hospital mortality associated with coronary artery bypass grafting. The Northern New England Cardiovascular Disease Study Group. [see comment]. JAMA 266 (1991) 803-809
33. Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. JAMA 273 (1991) 1421-1428
34. Perler B.A. The effect of statin medications on perioperative and long-term outcomes following carotid endarterectomy or stenting. Semin Vasc Surg 20 (2007) 252-258
35. McGirt M.J., Perler B.A., Brooke B.S., Woodworth G.F., Coon A., Jain S., et al. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. [see comment]. J Vasc Surg Nov 42 (2005) 829-836 discussion 836-827.
36. Kennedy J., Quan H., Buchan A.M., Ghali W.A., and Feasby T.E. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. [see comment]. Stroke 36 (2005) 2072-2076